Briefs: India Glycols and DACL Fine Chem
General

Briefs: India Glycols and DACL Fine Chem

DACL Fine Chem Limited has received Consent to establish (CTE) from GPCB for proposed plant of formulation chemicals and lithium based derivatives

  • By ICN Bureau | December 19, 2023

India Glycols allocated quota to supply 16.55 crore liters of Ethanol

India Glycols Limited has been allocated quantities through tender(s) participation for supply of 16.55 crore liters of Ethanol with an estimated value aggregating to Rs. 1,164 Crores under Ethanol Blended Petrol Programme ("EBPP") during Ethanol Supply Year from 1st November, 2023 till 31st October, 2024.

The company has been allocated quantities for supplying of Ethanol from its Grain based Ethanol plants (Kashipur and Gorakhpur) under Ethanol Blended Petrol Programme (EBPP).

DACL Fine Chem receives CTE from GPCB for proposed new plant

DACL Fine Chem Limited, wholly owned subsidiary of Diamines and Chemicals Limited, has received Consent to establish (CTE) from Gujarat Pollution Control Board (GPCB) for proposed plant of formulation chemicals and lithium based derivatives in unit of DACL Fine Chem Limited at Dahej - II Industrial Estate.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.